Peptide, Protein Or Amino Acid Patents (Class 436/86)
-
Publication number: 20150140139Abstract: The present invention relates to a composition for improving or promoting hair growth, which contains, as an active ingredient, a photosensitizer-peptide conjugate, and to a method for screening for the hair growth promoter using the active ingredients. ALA, which is the photosensitizer of the present invention, is preferably activated by LED radiation, and more preferably activated by radiation having a long wavelength of 650 to 675 nm. The peptide of the present invention is a peptide in which 3 to 7 amino acid residues are incorporated (most preferably, glycine-histidine-lysine), and may cooperate with the photosensitizer to enable very superior hair growth improving or promoting effects using light radiation. Further, the composition of the present invention may exhibit further superior effects when natural extracts (for example, Cimicifuga heracleifolia extracts, Scutellaria baicalensis extracts or Codonopsis lanceolata extracts) are added.Type: ApplicationFiled: May 8, 2013Publication date: May 21, 2015Inventors: Darren Williams, Da-Won Jung, Soon-Ho Yim
-
Publication number: 20150140124Abstract: The present invention relates to the BAD pathway's influence on development, progression, chemo-sensitivity, and overall survival for multiple human cancers and its potential as a therapeutic target to increase chemo-sensitivity. BAD pathway expression was associated with the development and/or progression of breast, colon, and endometrial cancers, relapse-free survival from breast cancer, and overall survival from ovarian, colon, and brain cancers. Expression was also associated with in vitro sensitivity to a range of cytotoxic agents. pBAD levels were higher in cancer versus immortalized normal cells and chemo-resistant versus—sensitive cancer cells and associated with increased cell proliferation.Type: ApplicationFiled: November 10, 2014Publication date: May 21, 2015Inventors: Johnathan M. Lancaster, Douglas C. Marchion, Yin Xiong
-
Publication number: 20150140593Abstract: A homologous series of neutrally charged compounds having at least one functional group bearing a positive charge and at least one functional group bearing a negative charge are advantageous retention index standards for liquid chromatography, especially for liquid chromatography-mass spectrometry (LC-MS) methods, more especially for LC-MS methods employing electrospray (ESI) or atmospheric pressure chemical ionization (APCI) ionization systems.Type: ApplicationFiled: March 15, 2013Publication date: May 21, 2015Inventor: Michael Arthur Quilliam
-
Patent number: 9034652Abstract: Colloidal formulation for staining proteins and methods of their use are provided.Type: GrantFiled: March 11, 2014Date of Patent: May 19, 2015Assignee: Bio-Rad Laboratories, Inc.Inventors: Christopher Belisle, Lee Olech, Thomas Berkelman, Praveena Garimella
-
Publication number: 20150132742Abstract: Microfluidic devices fabricated from paper that has been covalently modified to increase its hydrophobicity, as well as methods of making and using thereof are provided herein. The devices are typically small, portable, flexible, and both easy and inexpensive to fabricate. Microfluidic devices contain a network of microfluidic components, including microfluidic channels, microfluidic chambers, microwells, or combinations thereof, designed to carry, store, mix, react, and/or analyze liquid samples. The microfluidic channels may be open channels, closed channels, or combinations thereof. The microfluidic devices may be used to detect and/or quantify an analyte, such as a small molecules, proteins, lipids polysaccharides, nucleic acids, prokaryotic cells, eukaryotic cells, particles, viruses, metal ions, and combinations thereof.Type: ApplicationFiled: June 3, 2013Publication date: May 14, 2015Inventors: Martin Mwangi Thuo, Ramses V. Martinez, Ana C. Glavan, Wenjie Lan, Xinyu Liu, Jean-Francis Bloch, George M. Whitesides
-
Publication number: 20150132747Abstract: Methods of treating a subject having a condition characterized by at least one of neurodegeneration and neuroinflammation are provided. Methods of reducing astrogliosis in a subject having a condition characterized by increased astrogliosis are also provided. Methods of providing neuroprotection to a subject in need thereof are also provided.Type: ApplicationFiled: November 13, 2014Publication date: May 14, 2015Inventor: Matvey Lukashev
-
Publication number: 20150132746Abstract: Provided herein is technology relating to the collection of biological samples and particularly, but not exclusively, to compositions, methods, and uses related to using a biopolymer substrate to collect biological samples for analysis.Type: ApplicationFiled: May 29, 2013Publication date: May 14, 2015Inventors: Astrid Gjelstad, Lars Erik Eng Eibak, Anne Bee Hegge, Knut Einar Rasmussen, Stig Pedersen-Bjergaard
-
Publication number: 20150132794Abstract: A method of manufacturing a batch of sample containers optimized for culturing particular animal cells or binding particular proteins under particular growth conditions. When a customer requires a batch of sample containers, an appropriate surface is first selected by a testing process. A test container is provided which has a surface subdivided into a plurality of test areas, for example in a two-dimensional square array. Each test area has a pre-defined combination of surface properties including a micro- or nano-structure and these properties are varied from test area to test area. The animal cells or protein of interest are then tested under the particular conditions to be used. The test area that provides the ‘best’ conditions is then selected. The manufacture of a production batch of containers is then carried out, wherein the test areas in the production batch all copy the ‘best’ surface structure selected in the test.Type: ApplicationFiled: June 21, 2013Publication date: May 14, 2015Applicant: Sony DADC Austria AGInventors: Georg Bauer, Gottfried Reiter, Werner Balika, Christoph Mauracher
-
Patent number: 9029163Abstract: A system and method for creating a plurality of denaturation curves is disclosed. In accordance with certain embodiments, one variable, such as salt content, pH or another parameter, is varied to create a plurality of different buffer solutions. Each is then used to create a denaturation graph. The plurality of denaturation graphs allows analysis of the effect of that variable on protein stability.Type: GrantFiled: August 22, 2011Date of Patent: May 12, 2015Assignee: Avia Biosystems, Inc.Inventors: Richard Brown, Burleigh Hutchins, Ernesto Freire
-
Publication number: 20150126438Abstract: The invention provides diagnostic and prognostic methods and methods of evaluating treatment protocols for disorders such as obesity, diabetes, metabolic syndrome, cancer and vascular disease by detecting the levels of a novel isoform of ChREBP, termed ChREBP ?. The invention also provides nucleic acids, proteins, reporter constructs based on ChREBP ? and methods of identifying one or more agents that modulate the expression of a ChREBP ? target gene.Type: ApplicationFiled: January 22, 2013Publication date: May 7, 2015Inventors: Mark A. Herman, Barbara B. Kahn
-
Publication number: 20150125897Abstract: The present invention relates to a method and an apparatus for a fast thermo-optical characterisation of particles. In particular, the present invention relates to a method and a device to measure the stability of (bio)molecules, the interaction of molecules, in particular biomolecules, with, e.g. further (bio)molecules, particularly modified (bio)molecules, particles, beads, and/or the determination of the length/size (e.g. hydrodynamic radius) ofindividual (bio)molecules, particles, beads and/or the determination of length/size (e.g. hydrodynamic radius).Type: ApplicationFiled: October 2, 2014Publication date: May 7, 2015Applicant: Ludwig Maximilians Universität MünchenInventors: Stefan DUHR, Philipp Baaske
-
Publication number: 20150125456Abstract: The present invention provides a method for diagnosing and detecting diseases associated with colon. The present invention provides one or more proteins or fragments thereof, peptides or nucleic acid molecules differentially expressed in colon diseases (CCAT) and antibodies binds to CCAT. The present invention provides that CCAT is used as targets for screening agents that modulates the CCAT activities. Further the present invention provides methods for treating diseases associated with colon.Type: ApplicationFiled: October 22, 2014Publication date: May 7, 2015Applicant: CELERA CORPORATIONInventors: Yeounjin KIM, Tao HE, Steve RUBEN
-
Publication number: 20150126402Abstract: A method for quantifying metallothionein protein isomers is described herein. Such metallothionein isomer protein quantification is useful for detecting and monitoring disease. As illustrated herein, protein quantification is a more accurate measure of metallothionein induction than is mRNA quantification.Type: ApplicationFiled: May 17, 2013Publication date: May 7, 2015Inventors: John B. Shabb, Aaron Mehus, Wallace Muhonen, Donald A. Sens, Scott Garrett
-
Patent number: 9023656Abstract: A mass label for labelling and detecting a biological molecule by mass spectroscopy, which label comprises the following structure: X-L-M wherein X is a mass marker moiety comprising the following group: formula (I), wherein the cyclic unit is aromatic or aliphatic and comprises from 0-3 double bonds independently between any two adjacent atoms; each Z is independently N, N(R1), C(R1), CO, CO(R1), C(R1)2, O or S; X is N, C or C(R1); each R1 is independently H, a substituted or unsubstituted straight or branched C1-C6 alkyl group, a substituted or unsubstituted aliphatic cyclic group, a substituted or unsubstituted aromatic group or a substituted or unsubstituted heterocyclic group; and y is an integer from 0-10, L is a cleavable linker comprising an amide bond and M is a mass normalization moiety.Type: GrantFiled: July 26, 2006Date of Patent: May 5, 2015Assignee: Electrophoretics LimitedInventors: Christian Hamon, Josef Schwarz, Wolfgang Becker, Stefan Kienle, Karsten Kuhn, Juergen Schaefer
-
Publication number: 20150118155Abstract: The present invention provides a method of diagnosing the existence or risk of hyperthyroidism in a feline comprising measuring the level of expression of one or more biomarkers selected from the group consisting of e.g., IYD, TG, SLC5A5, NIS, TPO, TSHR, DUOX1, DUOX2 (ThOX), TGFB1, CSTD, DCN and SEPP1 and the expression products thereof, in a biological sample from the feline, wherein elevated expression of the one or more biomarkers in the sample relative to a control value for expression in a sample from a normal feline or feline population, or a baseline value from the feline, indicates the existence or risk of hyperthyroidism; a method of treating a feline so diagnosed; and compositions, reagents and kits for carrying out the specified methods.Type: ApplicationFiled: June 14, 2012Publication date: April 30, 2015Applicant: Hill's Pet Nutrition, Inc.Inventors: Samer Al-Murrani, Xiangming Gao
-
Publication number: 20150119273Abstract: The invention is based on the surprising discovery that as few as one episode of blast exposure increases the risk of CTE. Blast exposure is associated with chronic traumatic encephalopathy, impaired neuronal function, and persistent cognitive deficits in blast-exposed military veterans and experimental animals. Early diagnosis and assessment of risk permits physicians to prescribe treatment to reduce or slow progression of impairment before the onset of overt symptoms that become apparent decades after an initial insult or trauma to brain tissue. The invention provides methods and compositions for diagnosis and prognosis of individuals at risk of long term complications related to blast injury or concussive injury.Type: ApplicationFiled: May 16, 2013Publication date: April 30, 2015Inventors: Lee E. Goldstein, Ann C. Mckee, Neil W. Kowall
-
Patent number: 9017953Abstract: The present invention encompasses methods and compositions for detecting pathogenic bacteria. Additionally, the present invention encompasses methods and compositions for catalyzing the dismutation of superoxide radicals.Type: GrantFiled: May 20, 2013Date of Patent: April 28, 2015Assignee: Washington UniversityInventors: Jeffrey P. Henderson, Chia Hung, Kaveri Chaturvedi
-
Publication number: 20150111199Abstract: Methods of studying, interrogating, analyzing, and detecting particles, substances, and the like with near field light are described. Methods of identifying binding partners, modulators, inhibitors, and the like of particles, substances, and the like with near field light are described. In certain embodiments, the methods comprise immobilizing or trapping the particle, substance, and the like.Type: ApplicationFiled: March 15, 2013Publication date: April 23, 2015Inventors: Robert Hart, Bernardo Cordovez
-
Publication number: 20150104392Abstract: The present invention relates to compositions, biomarkers, and their use in treatment of cancer. In some embodiments, the invention relates to the use of several biomarkers in methods for determining the responsiveness of a human subject to a specific compound, methods for monitoring the efficacy of the compound, or methods for treating a human subject.Type: ApplicationFiled: October 3, 2014Publication date: April 16, 2015Inventor: WILLIAM G. RICE
-
Publication number: 20150104804Abstract: A method for manufacturing cubic diamond nanocrystals (10) comprising the following successive steps: (a) providing crystalline diamond powder where the maximum particle size of the powder is equal or more than 2 ?m and equal or less than 1 mm; (b) milling said crystalline micron diamond powder using nitrogen jet milling micronization so as to manufacture a fine powder; (c) nanomilling the fine powder of step b) using a planetary tungsten carbide ball mill; (d) acid treating the nanomilled powder of step c); (e) extracting the cubic diamond nanocrystals (10) by centrifugation. Advantageously round-shaped cubic diamond nanocrystals are manufactured.Type: ApplicationFiled: December 18, 2014Publication date: April 16, 2015Inventors: Patrick Curmi, Jean-Paul Boudou, Alain Thorel, Fedor Jelezko, Mohamed Sennour
-
Publication number: 20150104877Abstract: A reusable coating for a nanopore structure is disclosed herein. A nanopore structure includes a substrate comprising a nanochannel and a monolayer of a chemical compound disposed onto at least a portion of a surface of the nanochannel. The chemical compound forms a reversible bond with at least one analyte binding compound introduced into the nanochannel. Methods for making and using the reusable coating are also disclosed.Type: ApplicationFiled: November 4, 2013Publication date: April 16, 2015Applicant: International Business Machines CorporationInventors: Natalie Gunn, Jose M. Lobez Comeras, Priscilla Rogers, John Wagner
-
Patent number: 9005984Abstract: Methods and compositions are disclosed for determining feline proBNP or fragments thereof in a sample. In one method, feline proBNP or fragments thereof are determined by providing a feline sample, contacting the sample with at least one antibody that binds an epitope in the region from amino acids 68 to 80 of feline proBNP, and determining the presence of the feline proBNP or fragments thereof present in the sample. Antibodies that bind feline proBNP and kits comprising such antibodies are also disclosed.Type: GrantFiled: February 27, 2009Date of Patent: April 14, 2015Assignee: Biomedica Medizinprodukte GmbH & Co KGInventors: Wolfgang Woloszczuk, Gerhard Hawa
-
Patent number: 9005986Abstract: A method for rapidly measuring melatonin adulteration of Chinese patent medicines and healthcare foods comprises: (1) extracting melatonin added to a Chinese patent medicine or healthcare food by using ethyl acetate; and (2) adding p-dimethylaminocinnamaldehyde to the extracted solution, and observing color. The method is rapid, simple and convenient, has strong specificity, high accuracy, reaction sensitivity, and a wide application range, and is applicable to on-site detection of melatonin adulteration of a Chinese patent medicine or healthcare food.Type: GrantFiled: July 2, 2012Date of Patent: April 14, 2015Assignee: Shenzhen Institute For Drug ControlInventors: Tiejie Wang, Yi Lu, Lihe Xiao, Xiaoying Guan, Dongqi Han, Guo Yin, Jue Wang, Xueqing Li, Yan Yan
-
Patent number: 9005614Abstract: PRLR-specific antibodies are provided, along with pharmaceutical compositions containing such antibody, kits containing a pharmaceutical composition, and methods of preventing and treating cancer.Type: GrantFiled: November 22, 2010Date of Patent: April 14, 2015Assignees: Novartis AG, Xoma Technology Ltd.Inventors: Jason Damiano, Mohammad Luqman, Daniel Bedinger, Linda Masat, Amer Mirza, Genevieve Nonet
-
Publication number: 20150099305Abstract: Methods and assays for detecting S-sulfhydration of amino acids in proteins, polypeptides and peptides are provided. The method is a two-step “tag-switch” method employing two reagents consecutively to specifically label, with a detectable label, persulfide (—S—SH) linkages in proteins, polypeptides and peptides.Type: ApplicationFiled: October 7, 2014Publication date: April 9, 2015Inventors: Ming Xian, Dehui Zhang
-
Publication number: 20150099664Abstract: A method for characterizing the risk a subject will develop an autoimmune and/or alloimmune disease following tissue transplant includes obtaining a biological sample from the subject, wherein the subject has received the tissue transplant determining in the biological sample a level of at least one protein selected from Tables 1-4, comparing the measured level of the at least one protein to a control value, and characterizing a subject as at greater risk of developing an autoimmune disease and/or alloimmune disease if the level of at least one protein determined is increased or decreased compared to the control value.Type: ApplicationFiled: December 15, 2014Publication date: April 9, 2015Inventors: Mark Chance, Kenneth Cooke, Daniela Schlatzer
-
Publication number: 20150093765Abstract: The present invention relates to the use of soluble CD163 as a prognostic marker for the assessment of the risk for contracting a disorder, in particular for contracting diabetes and/or a liver disorder. The invention also relates to the use of CD163 as a prognostic marker for assessing lifetime expectancy.Type: ApplicationFiled: December 15, 2014Publication date: April 2, 2015Inventors: Søren Moestrup, Ruth Frikke-Schmidt, Anne Tybjaerg-Hansen, Holger J. Moller
-
Publication number: 20150093771Abstract: An analytical device for analysis of chemical or biological samples, a method of using such a device, based on rotation of the device, integrated sample dosing and optical detection, and a system comprising such a device are disclosed. The analytical device comprises a device body having a liquid processing unit. The liquid processing unit comprises a mixing chamber for mixing a sample with a reagent, a sample dosing chamber for delivering a defined volume of the sample to the mixing chamber, and a reagent channel for delivering the reagent to be mixed with the sample, wherein the mixing chamber also serves as a detection chamber.Type: ApplicationFiled: December 2, 2014Publication date: April 2, 2015Inventors: Patrick Griss, Rainer Jaeggi, Goran Savatic, Vuk Siljegovic
-
Patent number: 8993345Abstract: A method of producing functional molecule-containing silica nanoparticles on which a biomolecule is bonded, containing the steps of: allowing silica nanoparticles containing a functional molecule and having a thiol group on a surface thereof to coexist with a linker molecule having a maleimido group and a carboxyl group in an aprotic solvent, thereby allowing formation of a thioether bond between the thiol group and the maleimido group, and obtaining functional molecule-containing silica nanoparticles on which the linker molecule is bonded; and allowing the functional molecule-containing silica nanoparticles on which the linker molecule is bonded to coexist with carbodiimide and a biomolecule having an amino group in an aqueous solvent, thereby allowing formation of an amide bond between the carboxyl group active esterified by the carbodiimide, and the amino group of the biomolecule.Type: GrantFiled: October 25, 2013Date of Patent: March 31, 2015Assignee: Furukawa Electric Co., Ltd.Inventors: Hideki Aizawa, Michio Ohkubo, Masataka Nishida
-
Patent number: 8993334Abstract: The present invention provides methods for separating proteins from a protein mixture. In one aspect, a method for separating a high concentration protein mixture into a bound protein fraction and a flow-through protein fraction can include delivering a protein mixture through an ion exchange column at a fixed pH and a fixed salt concentration. The fixed pH and the fixed salt concentration have been preselected to cause separation of the protein mixture into a bound protein fraction and a flow-through protein fraction. In this case, the bound protein fraction binds to the ion exchange column and the flow-though protein fraction flows though the ion exchange column. The method can further include receiving the flow-through protein fraction from the ion exchange column separate from the bound protein fraction, wherein either the bound protein fraction or the flow-through fraction contains a protein of interest.Type: GrantFiled: November 5, 2012Date of Patent: March 31, 2015Inventor: Anthony R. Torres
-
Publication number: 20150087073Abstract: A method for identifying a polypeptide a specimen can include (i) treating a specimen suspected of comprising an insulin with a base; (ii) extracting a first fraction of the treated specimen by solid phase extraction using a mixed mode or polymeric reversed-phase media and a first solvent comprising an acid; (iii) separating a component of the first fraction by liquid chromatography using a chromatographic surface including a hydrophobic surface group and one or more ionizable modifiers, and a second solvent comprising an acid; and (iv) analyzing the component of the first fraction by mass spectroscopy, thereby identifying the polypeptide, if present, using a signal corresponding to a sequence fragment ion from the polypeptide. The signal can correspond to an intact multiply charged precursor fragment selected in a first quadrupole and its corresponding sequence fragment ion selected in a final quadrupole.Type: ApplicationFiled: March 14, 2013Publication date: March 26, 2015Inventors: Erin E. Chambers, Martha Stapels, Joanne Mather
-
Publication number: 20150087074Abstract: Described herein are devices and methods for identifying the existence of an oral condition in a subject.Type: ApplicationFiled: December 12, 2014Publication date: March 26, 2015Inventors: Elizabeth Gittins, Harsh M. Trivedi, Sharon Kennedy, Madhusudan Patel
-
Patent number: 8980638Abstract: Provided herein are methods and compositions for the prognostic evaluation of a patient suspected of having, or having, cancer by assessing the expression of IMP3 in a biological sample of a patient. Methods can be used at the time of initial diagnosis of malignant tumors to identify a group of patients with a high potential to develop progression or metastasis later. Therefore, methods not only are able to provide very useful prognostic information for patients but also can help clinicians to select a candidate patient likely to benefit from early and aggressive cancer therapy. Methods and compositions for the treatment of cancer associated with expression of IMP3 are also provided.Type: GrantFiled: December 18, 2012Date of Patent: March 17, 2015Assignee: University of MassachusettsInventor: Zhong Jiang
-
Publication number: 20150072356Abstract: The present invention provides a method for diagnosing venous thromboembolism (VTE), comprising: detecting the level of an integrin ?1 subunit, an integrin ?2 subunit, and/or an integrin ?3 subunit in a blood sample. Also provided is a reagent kit for diagnosing VTE, comprising a substance capable of specifically binding to the integrin ?1 subunit, the integrin ?2 subunit, and/or the integrin ?3 subunit.Type: ApplicationFiled: April 18, 2012Publication date: March 12, 2015Inventor: Lemin Wang
-
Publication number: 20150072434Abstract: The invention generally relates to methods for assessing risk of bone fracture. In certain embodiments, methods of the invention involve a) conducting an assay to determine a characteristic of keratinized tissue obtained from a mammal, b) analyzing at least one bone-fracture risk factor associated with the mammal, and c) correlating results from steps (a) and (b), thereby assessing the risk of bone fracture of a bone of the mammal.Type: ApplicationFiled: June 19, 2014Publication date: March 12, 2015Inventors: Mark Robert Towler, Ernest Poku
-
Patent number: 8975030Abstract: The present invention relates to the diagnosis and treatment of cancer, and specifically to a method of diagnosing the presence, status or metastasis of cancer by detecting plasma Hsp90? having the amino acid sequence of SEQ ID NO:1 as a tumor marker. In addition, the present invention also relates to a method for the treatment of cancer and metastasis.Type: GrantFiled: March 4, 2013Date of Patent: March 10, 2015Assignees: Tsinghua University, Protgen Ltd.Inventors: Yongzhang Luo, Xiaomin Song, Xiaofeng Wang, Wei Zhuo, Guodong Chang, Yan Fu
-
Publication number: 20150064719Abstract: Methods for assessing the condition of keratinized structures, including hair, in particular methods to determine the condition of keratinized structures in relation to suitability for analysis of analytes of interest in a test sample, are presented. The methods comprise contacting the keratinized structure with a non-proteolytic reducing agent and an optional proteolytic agent. The methods further include inspection of the hair sample, or measurement of free protein eluted from the keratinized structure, after reduction and optional proteolysis to determine condition prior to analyte identification and quantitation by known techniques such as immunoassays.Type: ApplicationFiled: August 28, 2014Publication date: March 5, 2015Inventors: Virginia Hill, Michael I. Schaffer, Elvan Loni, Gary Neil Stowe
-
Patent number: 8969026Abstract: Methods for liquid-liquid extraction, as can be effected using polymeric reverse micelles, such methods as can be used in conjunction with various mass spectrometric techniques.Type: GrantFiled: August 11, 2008Date of Patent: March 3, 2015Assignee: University of MassachusettsInventors: Sankaran Thayumanavan, Richard Vachet, Elamprakash N. Savariar, Marianny Y. Combariza
-
Patent number: 8969287Abstract: Disclosed here is a method for measuring the kinetics (i.e., the molecular flux rates-synthesis and breakdown or removal rates) of a plurality of proteins or organic metabolites in living systems. The methods may be accomplished in a high-throughput, large-scale automated manner, by using existing mass spectrometric profiling techniques and art well known in the fields of static proteomics and static organeomics, without the need for additional biochemical preparative steps or analytic/instrumental devices.Type: GrantFiled: June 19, 2013Date of Patent: March 3, 2015Assignee: The Regents of the University of CaliforniaInventor: Marc K. Hellerstein
-
Patent number: 8969252Abstract: The present invention includes methods for producing magnetic nanocrystals by using a biological molecule that has been modified to possess an amino acid oligomer that is capable of specific binding to a magnetic material.Type: GrantFiled: April 7, 2011Date of Patent: March 3, 2015Assignee: Board of Regents, University of Texas SystemInventors: Angela M. Belcher, Brian D. Reiss, Chuanbin Mao, Daniel J. Solis
-
Publication number: 20150056190Abstract: The invention provides methods and compositions to detect expression of one or more biomarkers for identifying and treating patients who are likely to be responsive to VEGF antagonist therapy. The invention also provides kits and articles of manufacture for use in the methods.Type: ApplicationFiled: March 14, 2013Publication date: February 26, 2015Applicant: Genentech, Inc.Inventors: Priti Hegde, Maike Schmidt, Ru-Fang Yeh
-
Publication number: 20150056710Abstract: Simultaneous Multiple Sample Light Scattering systems and methods can be used to for polymer stability testing and for applying stressors to polymer or colloid solutions including heat stress, ultrasound, freeze/thaw cycles, shear stress and exposure to different substances and surfaces. among others, that create a polymer stress response used to characterize the polymer solution and stability.Type: ApplicationFiled: August 20, 2014Publication date: February 26, 2015Applicants: ADVANCED POLYMER MONITORING TECHNOLOGIES, INC., THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUNDInventors: Wayne Frederick Reed, Michael Felix Drenski, Alex Wayne Reed
-
Patent number: 8962340Abstract: A real-time portable and rapid detection assay to identify the presence of biologically active toxins such as botulinum toxins. The proteolytic activity of BoNT/A is measured using a peptide cleavage assay, where a fluorescent substrate is cleaved by BoNT/A, resulting in increased fluorescence. This fluorescence can be monitored in real-time using a fluorescence detection instrument, such as a real-time PCR system that has been modified to implement a detection algorithm specific to the identification of the target toxin.Type: GrantFiled: March 15, 2013Date of Patent: February 24, 2015Assignee: SRC, Inc.Inventors: Kenton Arthur Doctor, Stacey Ann Massulik, Frances Louise Stites, Timothy Francis Moshier, Jeffrey Harold Mills, Lisa Helen Chamberlin, Deborah L. Plochocki, Olivia Jennifer Barrett, Huda Sirageldin Suliman
-
Patent number: 8961937Abstract: The present invention relates to a composition for detecting beta amyloid aggregates and a composition for diagnosing beta amyloid aggregation disease, comprising a 2-styrilpyridizine-3(2H)-one derivative or its pharmaceutically acceptable salt, to a diagnostic kit for diagnosing beta amyloid aggregation disease comprising said composition and to a method for detecting beta amyloid aggregates using said compositions to provide information for beta amyloid aggregation disease diagnosis.Type: GrantFiled: March 13, 2013Date of Patent: February 24, 2015Assignee: Korea Atomic Energy Research InstituteInventors: Yong Dae Park, Jeong Hoon Park, Yong Jin Yoon, Seung Tae Yang, Min Goo Hur
-
Patent number: 8962705Abstract: A method for removing cauxin in cat urine and a material for removing cauxin are provided. The material for removing cauxin in cat urine comprises a polymer substrate on which surface a trifluoroketone derivative is immobilized via dithiol.Type: GrantFiled: February 17, 2011Date of Patent: February 24, 2015Assignees: National University Corporation Chiba University, Incorporated National University Iwate University, Nippon Zenyaku Kogyo Co., Ltd.Inventors: Shinya Matsuno, Kyoichi Saito, Tetsuro Yamashita, Ayako Ito, Yasuyuki Suzuta
-
Publication number: 20150051096Abstract: Provided in certain embodiments are new methods for forming azido modified biomolecule conjugates of reporter molecules, carrier molecules or solid support. In other embodiments are provided methods for enzymatically labeling a biomolecules with an azide group.Type: ApplicationFiled: July 14, 2014Publication date: February 19, 2015Inventors: Brian AGNEW, Kyle GEE, Tamara NYBERG
-
Publication number: 20150044715Abstract: Disclosed is a method which enables semiquantitative or quantitative determination of the ratio between cysteine and formylglycine residues in a protein. The method includes (a) a step of labeling the protein (i) with a halogen-substituted carboxylic acid, (ii) with a halogen-substituted carboxylic acid amide, and (iii) with a halogen-substituted carboxylic acid and then with hydrazine, or with a halogen-substituted carboxylic acid and then by oximation, (b) a step of digesting each labeled protein to provide a corresponding mixture of peptide fragments, (c) a step of subjecting each mixture to reverse phase chromatography to separate the peptide fragments from each other to produce a chromatogram, (d) a step of comparing the produced chromatograms with each other to identify the peak corresponding to the peptide fragment that contained a cysteine residue and the peak corresponding to the peptide fragment that contained a formylglycine residue.Type: ApplicationFiled: December 18, 2012Publication date: February 12, 2015Inventor: Tetsuo Yokoyama
-
Publication number: 20150045245Abstract: The application discloses new biomarkers or test panels useful in systemic inflammatory conditions such as sepsis; methods for the diagnosis, prediction, prognosis and/or monitoring systemic inflammatory conditions such as sepsis based on measuring said biomarkers or test panels; and related kits and devices.Type: ApplicationFiled: December 7, 2012Publication date: February 12, 2015Applicant: BIOCARTIS NVInventors: Griet Vanpoucke, Katleen Verleysen, Yven Van Herrewege
-
Patent number: 8951804Abstract: Provided herein is a method of sample analysis. In certain embodiments, the method comprises: a) cross-linking protein of a cell using a first compound to produce a first cross-linked product comprising cross-linked protein, and RNA; b) contacting the first cross-linked product and a second compound under conditions by which an oligonucleotide portion of the second compound hybridizes to the RNA; c) activating a reaction the first and second compound, thereby covalently crosslinking the oligonucleotide to the cross-linked protein to produce a second cross-linked product; d) isolating the second cross-linked product using an affinity tag; and e) analyzing the isolated second cross-linked product. Compounds for performing the method are also provided.Type: GrantFiled: October 6, 2011Date of Patent: February 10, 2015Assignee: Agilent Technologies, Inc.Inventors: Brian Phillip Smart, Robert A. Ach
-
Patent number: 8945932Abstract: The invention provides methods for detecting and isolating phosphomolecules using phosphoaffinity materials that comprise a hydrated metal oxide. In an embodiment, a method for detecting a phosphomolecule in a sample involves (a) contacting a sample with a phosphoaffinity material comprising a hydrated metal oxide, under conditions wherein a phosphomolecule is capable of binding to the phosphoaffinity material to form a phosphomolecule-phosphoaffinity material complex, and (b) detecting formation of a phosphomolecule-phosphoaffinity material complex, thereby detecting a phosphomolecule in the sample.Type: GrantFiled: July 6, 2005Date of Patent: February 3, 2015Assignee: PerkinElmer Health Sciences, Inc.Inventors: Wayne F. Patton, Alvydas Mikulskis, Eva Golenko